L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 6:59 pm Sale | 2025-08-14 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 164,300 4.990% | -120,700 (-42.35%) | Filing |
| 2025-06-23 4:08 pm Purchase | 2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 285,000 9.950% | 265,000 (+1325.00%) | Filing |
| 2025-06-23 4:07 pm Purchase | 2025-04-26 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 20,000 0.700% | 20,000 (New Position) | Filing |